Balversa 4 MG
Ended Awarded
- Contract number
- 36C24525N0868
- Awardee
-
Janssen Biotech Inc. UEI NVYMGFA53MN7
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $18,804
Award facts
- Contract value 100% obligated
- $18,803.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
About this award
Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., was awarded a firm fixed-price delivery order valued at $18,803.91 by Veterans Integrated Service Network 5 (VISN 5) on August 6, 2025, with an ultimate completion date of August 7, 2025. The contract covers the delivery of BALVERSA (erdafitinib), a specialized oncology medication, to the Veterans Health Administration facility in Carrollton, Texas. This delivery order carries no set-aside designation and is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), which enables the Department of Veterans Affairs to efficiently procure critical specialty medications for veteran healthcare services.
This award represents a single delivery transaction under Janssen Biotech's broader federal contract relationships with the VA, which include a $15 million single-award Blanket Purchase Agreement and a $6.8 billion multiple-award Federal Supply Schedule contract, both focused on oncology medications. As a subsidiary of Johnson & Johnson specializing in biologic therapies and oncology products, Janssen Biotech serves as a key supplier of advanced pharmaceutical treatments to support comprehensive healthcare delivery across multiple Veterans Integrated Service Networks, ensuring consistent access to critical cancer treatment medications for the veteran population.
Quick answers
Who was awarded contract 36C24525N0868?
36C24525N0868 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on August 6, 2025.
How much is contract 36C24525N0868 worth?
The government has obligated $18,804 on 36C24525N0868.
Is contract 36C24525N0868 an order under another contract?
Yes. 36C24525N0868 is a delivery order under 36F79724D0176, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0868 competed?
The extent of competition for 36C24525N0868 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award